Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 655

1.

Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.

Bonaros N, Sondermeijer H, Wiedemann D, Schlechta B, Schachner T, Schuster M, Seki T, Martens TP, Itescu S, Kocher AA.

J Thorac Cardiovasc Surg. 2011 Sep;142(3):687-96, 696.e1-2. doi: 10.1016/j.jtcvs.2011.01.014. Epub 2011 Mar 8.

2.

CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.

Bonaros N, Sondermeijer H, Schuster M, Rauf R, Wang SF, Seki T, Skerrett D, Itescu S, Kocher AA.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):1044-53. doi: 10.1016/j.jtcvs.2007.12.067. Epub 2008 Jul 7. Erratum in: J Thorac Cardiovasc Surg. 2010 Apr 1;139(4):1089. Sondermejer, H [corrected to Sondermeijer, H].

3.

Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):321-9.

4.

Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.

Kanellakis P, Slater NJ, Du XJ, Bobik A, Curtis DJ.

Cardiovasc Res. 2006 Apr 1;70(1):117-25. Epub 2006 Feb 23.

5.

SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.

Ghadge SK, Mühlstedt S, Ozcelik C, Bader M.

Pharmacol Ther. 2011 Jan;129(1):97-108. doi: 10.1016/j.pharmthera.2010.09.011. Epub 2010 Oct 20. Review.

PMID:
20965212
6.

Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.

Wright LM, Maloney W, Yu X, Kindle L, Collin-Osdoby P, Osdoby P.

Bone. 2005 May;36(5):840-53. Epub 2005 Mar 24.

PMID:
15794931
7.

Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.

Morimoto H, Takahashi M, Shiba Y, Izawa A, Ise H, Hongo M, Hatake K, Motoyoshi K, Ikeda U.

Am J Pathol. 2007 Sep;171(3):755-66. Epub 2007 Jul 19.

8.

Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.

Dong F, Harvey J, Finan A, Weber K, Agarwal U, Penn MS.

Circulation. 2012 Jul 17;126(3):314-24. doi: 10.1161/CIRCULATIONAHA.111.082453. Epub 2012 Jun 9.

9.

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.

Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S.

Nat Med. 2001 Apr;7(4):430-6.

PMID:
11283669
10.

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.

Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S.

Circulation. 2004 Apr 6;109(13):1615-22. Epub 2004 Mar 22.

12.

Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.

Brunner S, Winogradow J, Huber BC, Zaruba MM, Fischer R, David R, Assmann G, Herbach N, Wanke R, Mueller-Hoecker J, Franz WM.

FASEB J. 2009 Feb;23(2):351-61. doi: 10.1096/fj.08-109462. Epub 2008 Sep 30.

13.

Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.

Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Jia EZ, Zhang FM, Cao KJ, Xu ZQ, Ma WZ.

Clin Chim Acta. 2007 Jun;381(2):114-8. Epub 2007 Feb 23.

PMID:
17400203
14.

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor.

Tan Y, Shao H, Eton D, Yang Z, Alonso-Diaz L, Zhang H, Schulick A, Livingstone AS, Yu H.

Cardiovasc Res. 2007 Mar 1;73(4):823-32. Epub 2006 Dec 23.

15.

Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.

Tong Y, Xu W, Han H, Chen Y, Yang J, Qiao H, Hong D, Wu Y, Zhou C.

Phytomedicine. 2011 Apr 15;18(6):443-50. doi: 10.1016/j.phymed.2010.10.009. Epub 2010 Dec 13.

PMID:
21146968
16.

Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.

Krishnamurthy P, Thal M, Verma S, Hoxha E, Lambers E, Ramirez V, Qin G, Losordo D, Kishore R.

Circ Res. 2011 Nov 11;109(11):1280-9. doi: 10.1161/CIRCRESAHA.111.248369. Epub 2011 Sep 29.

17.

Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.

Atluri P, Liao GP, Panlilio CM, Hsu VM, Leskowitz MJ, Morine KJ, Cohen JE, Berry MF, Suarez EE, Murphy DA, Lee WM, Gardner TJ, Sweeney HL, Woo YJ.

Ann Thorac Surg. 2006 May;81(5):1728-36.

PMID:
16631663
18.

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF.

Misao Y, Takemura G, Arai M, Ohno T, Onogi H, Takahashi T, Minatoguchi S, Fujiwara T, Fujiwara H.

Cardiovasc Res. 2006 Aug 1;71(3):455-65. Epub 2006 May 9.

19.
20.

Pathways implicated in stem cell migration: the SDF-1/CXCR4 axis.

Vagima Y, Lapid K, Kollet O, Goichberg P, Alon R, Lapidot T.

Methods Mol Biol. 2011;750:277-89. doi: 10.1007/978-1-61779-145-1_19.

PMID:
21618098
Items per page

Supplemental Content

Write to the Help Desk